Grippe-Peak in Spain: Between Lottery and Christmas

Flu curve alarm: Peak between lottery and Christmas

The current flu season in Spain comes with a warning repeated in offices and bars: the infection peak is expected between December 22, the day of the lottery draw, and December 25, Christmas. As one early comment summarized: "It is calculated that the flu peak will arrive between the 22nd lottery draw and the 25th Christmas Day." Translated: the bicho travels on the same bus as the nougat.

The figure backing this antiestéticar is not a hunch. Data indicates that last season, flu caused more than 33,000 hospitalizations, 1,811 ICU admissions, and 1,825 deaths in Spain between October and May, making it the country's main respiratory bicho. With this precedent, authorities' insistence on vaccination has undeniable logic.

Why does this year's flu worry more than other seasons?

The strongest argument circulating is the variant. Preliminary data point to the dominant strain being H3N2 and, within it, a new subtype, the K subclade. The consequence is twofold: more infections and faster spread. It is the kind of combination that collapses emergency rooms before staff can even hang up festive decorations.

Added to this is the calendar. Travel during holidays, company dinners, and family gatherings act as a logistical multiplier for the bicho. Some argue that after the holiday break, spread will be inevitable "in every corner of the country." This is not a risky prediction: it is the usual mechanics of any respiratory epidemic in a country moving en masse.

The institutional response is measured in doses. In the Basque Country, fewer than half a million vaccines have been administered, compared to two million two hundred thousand nationwide, according to available counts. The comparison is not flattering for the autonomous community, especially when the official message is precisely to get vaccinated.

Vaccines, skepticism, and the ghost of the 2020 season

The topic quickly drifts to where it always ends: trust in the vaccine. Part of the analysis argues that flu vaccine effectiveness is limited and its result is "completely random," explaining why it hasn't worked well this year either. Opposing this is the classic health argument: flu lasts a week, but for the elderly and chronically ill, the equation changes completely.

Collective memory plays tricks. Some recall that during the winter of 2020, hardly any flu cases were recorded, interpreting it as proof that measures then worked, or as proof that something doesn't add up. The debate about what peine with flu that season remains open, and each new season reopens it.

Skepticism has degrees. From those who simply say "flu passes and you're fine again in a week" to those who claim pharmaceutical companies have an economic interest in keeping antiestéticar alive every winter. Between these extremes lies almost everything, including reliance on home remedies like purple garlic or ginger infusions, which appear in conversation as alternatives to vaccination.

The flu business: sick leave, overtime, and extra masks

Not everything is ideology. Flu also has an immediate economic translation. A worker sums it up bluntly: covering a colleague on sick leave due to flu earns him 500 euros extra. It is the friendly face of the bicho for those working overtime, and proof that each flu season moves real money in sick leave, substitutions, and lost productivity.

The other side is exaggeration. Some describe, ironically, seeing people driving alone with masks, or acquaintances wearing "two masks inside the house." Mockery of excessive health zeal is a genre in itself, and this year was no exception.

The most repeated anecdote is of an acquaintance who went to get vaccinated for flu and other things at the start of the week and ended up with a stroke. It is the type of story that circulates without verification and should be handled with care: an isolated case proves nothing, especially when used to discourage vaccination. Temporal correlation is not causality, although the narrative works better the more dramatic it is.

Flu as a social thermometer

Beyond epidemiology, the flu season has become an attitude test. There are those who bundle up and haven't caught a cold in years, those who don't leave home at Christmas and consider solitude "the height of freedom," and those who see every vaccination campaign as a control operation. The flu is secondary; what is debated is whom to trust.

The cautious prediction is simple: if the peak arrives between the lottery and Christmas, emergency rooms will feel it, and last season's figures will serve as reference. If the variant turns out less aggressive than antiestéticared, next season we will discuss exactly the same thing again. Flu gives no respite, nor does the discussion about it.